These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 5047465)

  • 1. The use of macromolecules as carriers of cytotoxic groups (part II) nitrogen mustard--protein complexes.
    Szekerke M; Wade R; Whisson ME
    Neoplasma; 1972; 19(3):211-5. PubMed ID: 5047465
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of macromolecules as carriers of cytotoxic groups (part I) conjugates of nitrogen mustards with proteins, polypeptidyl proteins and polypeptides.
    Szekerke M; Wade R; Whisson ME
    Neoplasma; 1972; 19(3):199-209. PubMed ID: 5065390
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards area.
    Niculescu-Duvăz I; Feyns V; Dobre V
    Cancer Treat Rep; 1978 Dec; 62(12):2045-54. PubMed ID: 751714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The mechanism of tumor drug resistance].
    Kulik GI
    Vopr Onkol; 1969; 15(11):60-4. PubMed ID: 5368841
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the growth-inhibiting effect of some new N mustard compounds on Ehrlich ascites carcinoma, Nemeth-Kellner lymphoma (ascites form) and solid sarcoma 180].
    Jugstand W; Gutsche W; Wiangke H
    Arzneimittelforschung; 1966 May; 16(5):634-7. PubMed ID: 6014431
    [No Abstract]   [Full Text] [Related]  

  • 6. Transport and cytotoxicity of amino acid nitrogen mustards: implications for the design of more selective antitumor agents.
    Vistica DT; Ahmad S; Fuller R; Hill J
    Fed Proc; 1986 Sep; 45(10):2447-2450. PubMed ID: 3743787
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular pharmacokinetics of the phenylalanine mustards.
    Vistica DT
    Pharmacol Ther; 1983; 22(3):379-406. PubMed ID: 6361804
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of serotonin on the antineoplastic activity and toxicity of sarcolysin and dopan].
    Mal'tseva LF
    Farmakol Toksikol; 1966; 29(6):698-701. PubMed ID: 6000367
    [No Abstract]   [Full Text] [Related]  

  • 9. Some serum protein nitrogen mustard complexes with high chemotherapeutic selectivity.
    Wade R; Whisson ME; Szerkerke M
    Nature; 1967 Sep; 215(5107):1303-4. PubMed ID: 6052739
    [No Abstract]   [Full Text] [Related]  

  • 10. Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin.
    Noort D; Hulst AG; Jansen R
    Arch Toxicol; 2002 Mar; 76(2):83-8. PubMed ID: 11914777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of cure of large plasma cell tumors.
    Whisson ME; Connors TA; Jeney A
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):825-31. PubMed ID: 5958003
    [No Abstract]   [Full Text] [Related]  

  • 12. The presence in rat and human prostate of proteins that bind steroid-cytostatic complexes.
    Forsgren B; Björk P; Carlström K; Gustafsson JA; Pousette A; Högberg B
    Prog Clin Biol Res; 1981; 75A():391-407. PubMed ID: 7339627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enzymatically decomposable specific transport forms of cancerostatics. 2. Chloro-substituted 4-[N,N-bis-(2-chlorethyl)-amino[-phenyl-O-beta-D-glucopyranosides and -Xylopyranosides].
    Schwabe K; Graffi A
    Pharmazie; 1975 Feb; 30(2):70-4. PubMed ID: 238226
    [No Abstract]   [Full Text] [Related]  

  • 14. Alkylation of the DNA of sensitive and resistant tumours by a nitrogen mustard derivative.
    Connors TA; Double JA
    Int J Cancer; 1970 May; 5(3):375-83. PubMed ID: 5452070
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of phenesterin on glial tumors of the mouse brain].
    Iablonovskaia LIa; Degteva SA
    Arkh Patol; 1965; 27(12):60-3. PubMed ID: 5875703
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenesterin (NSC-104469)--clinical brochure.
    Vollmer EP; Taylor DJ; Masnyk IJ; Cooney D; Levine B; Piczak C; Trench L
    Cancer Chemother Rep 3; 1973 Jan; 4(1):103-19. PubMed ID: 4634116
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationships between chemical structure and biological activity in azomethines with nitrogen mustard groups on Ehrlich ascites tumor of the white mouse. 2. Azomethine without N-mustard groups as comparative substances and N-mustard azomethine with additional substitutions in the phenyl group].
    Schulze W; Gutsche W; Jungstand W
    Arzneimittelforschung; 1967 May; 17(5):605-7. PubMed ID: 5631589
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antineoplastic activity of new preparations from the chlorethylamine group not affecting hemopoiesis].
    Vasil'eva LS; D'iachkovskaia RF; Shuppe NG; Parkhomenko II; Surkova NI
    Izv Akad Nauk SSSR Biol; 1970; 3():459-63. PubMed ID: 5491977
    [No Abstract]   [Full Text] [Related]  

  • 19. A study on the mechanism of resistance to nitrogen mustard (HN2) in Ehrlich ascites tumor cells: comparison of uptake of HN2-14-C into sensitive and resistant cells.
    Wolpert MK; Ruddon RW
    Cancer Res; 1969 Apr; 29(4):873-9. PubMed ID: 5775714
    [No Abstract]   [Full Text] [Related]  

  • 20. The need for additional alkylating agents.
    Connors TA
    Cancer Res; 1969 Dec; 29(12):2433-7. PubMed ID: 5369691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.